Definitive Healthcare redujo sus pronósticos de ganancias Q4 y FY 2024, causando que su stock baje a $4.24. Definitive Healthcare cut its Q4 and FY 2024 earnings forecasts, causing its stock to drop to $4.24.

Definitive Healthcare (DH) actualizó su orientación de ganancias Q4 2024, esperando EPS de 0,070 e ingresos de $ 60,0 millones a $ 61,0 millones. Definitive Healthcare (DH) updated its Q4 2024 earnings guidance, expecting EPS of 0.070 and revenues of $60.0 million to $61.0 million. Para el FY 2024, la guía EPS de la compañía es 0,340 a 0,350. For FY 2024, the company's EPS guidance is 0.340 to 0.350. Las acciones de DH cayeron $0.07 a $4.24 el viernes. DH's stock fell $0.07 to $4.24 on Friday. Los analistas han dado a la acción una calificación de consenso de "Hold" con un precio objetivo promedio de $5.81. Analysts have given the stock a "Hold" consensus rating with an average target price of $5.81. Definitive Healthcare proporciona una plataforma de inteligencia comercial sanitaria SaaS. Definitive Healthcare provides a SaaS healthcare commercial intelligence platform.